Medtronic approved to start pivotal trial to evaluate new extended wear infusion set
Medtronic announced it received investigational approval from the FDA to proceed with a pivotal trial for a new extended wear infusion set. The goal of the study will be to collect clinical data to support the use of the extended wear infusion set for up to seven days. August 16, 2019